XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

U.S. Aerovate Therapeutics, Boeing, Wingstop



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop</title></head><body>

June 18 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday.


HIGHLIGHTS


* Aerovate Therapeutics Inc AVTE.O: TD Cowen cuts to hold from buy

* Boeing BA.N: RBC cuts target price to $210 from $215

* Mirum Pharmaceuticals Inc MIRM.O: Evercore ISI raises target price to $62 from $53

* Transdigm Group Inc TDG.N: RBC raises target price to $1,500 from $1,400

* Wingstop Inc WING.O: Stifel raises target price to $460 from $420

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.


* Aaron's Company Inc AAN.N: Truist Securities raises target price to $10.10 from $8

* Abbvie Inc ABBV.N: Piper Sandler raises target price to $190 from $185

* Addus Homecare Corp ADUS.O: TD Cowen raises target price to $128 from $119

* Aerovate Therapeutics Inc AVTE.O: Guggenheim cuts to neutral

* Aerovate Therapeutics Inc AVTE.O: TD Cowen cuts to hold from buy

* Apple Inc AAPL.O: JP Morgan raises target price to $245 from $225

* Arhaus Inc ARHS.O: Jefferies raises target price to $22 from $19

* Beyond Inc BYON.N: BofA Global Research cuts price objective to $15.5 from $19

* Beyond Inc BYON.N: Jefferies cuts target price to $15 from $18

* Boeing BA.N: RBC cuts target price to $210 from $215

* Carmax Inc KMX.N: Mizuho cuts target price to $72 from $75

* Carmax Inc KMX.N: Truist Securities cuts target price to $66 from $72

* Casella Waste Systems Inc CWST.O: Stifel raises target price to $110 from $105

* Celldex Therapeutics CLDX.O: Stifel initiates coverage with buy rating; PT $58

* Chegg Inc CHGG.N: Jefferies cuts target price to $2.50 from $4

* Chipotle Mexican Grill CMG.N: Argus Research raises PT to $3,888 from $3,668

* Chromocell Therapeutics CHRO.A: Alliance Global Partners initiates coverage with buy rating; PT $8.50

* Clean Harbors Inc CLH.N: Stifel raises target price to $240 from $230

* Corning Inc GLW.N: Mizuho raises target price to $42 from $36

* Corteva Inc CTVA.N: Mizuho cuts target price to $60 from $61

* Darden Restaurants Inc DRI.N: Deutsche Bank cuts target price to $180 from $183

* Digitalbridge Group Inc DBRG.N: Deutsche Bank cuts target price to $17 from $21

* Digitalbridge Group Inc DBRG.N: KBW cuts target price to $17.75 from $18.5

* Energy Transfer LP ET.N: Mizuho raises target price to $20 from $19

* Geovax Labs GOVX.O: H.C. Wainwright adjusts PT to $8 to reflect 1-for-15 reverse stock-split

* Granite Ridge Resources Inc GRNT.N: Gerdes Energy Research initiates with buy rating

* Granite Ridge Resources Inc GRNT.N: Gerdes Energy Research initiates with PT $7

* Humacyte Inc HUMA.O: TD Cowen raises target price to $7.5 from $6

* Innoviva Inc INVA.O: Cantor Fitzgerald initiates coverage with overweight rating

* Juniper Networks Inc JNPR.N: Argus Research raises to buy from hold

* Knife River Corp KNF.N: Stephens initiates coverage with overweight rating; PT $85

* Kroger Co KR.N: BMO raises target price to $60 from $58

* Kroger Co KR.N: BMO raises to outperform from market perform

* Levi Strauss & Co LEVI.N: TD Cowen raises target price to $26 from $23

* Loar Holdings Inc LOAR.N: RBC raises target price to $65 from $60

* McCormick & Company Inc MKC.N: Jefferies cuts target price to $73 from $77

* Micron Technology Inc MU.O: BofA Global Research adds stock to its U.S. 1 list

* Micron Technology Inc MU.O: Stifel raises target price to $165 from $140

* Micron Technology Inc MU.O: Wedbush raises target price to $170 from $130

* Mirum Pharmaceuticals MIRM.O: Morgan Stanley raises target price to $57 from $53

* Mirum Pharmaceuticals MIRM.O: Citigroup raises target price to $64 from $38

* Mirum Pharmaceuticals MIRM.O: Evercore ISI raises target price to $62 from $53

* Mirum Pharmaceuticals MIRM.O: JP Morgan raises target price to $39 from $31

* Mirum Pharmaceuticals MIRM.O: Raymond James raises target price to $71 from $60

* Montrose Environmental Group Inc MEG.N: Stifel raises target price to $56 from $51

* Nurix Therapeutics Inc NRIX.O: H.C. Wainwright raises target price to $26 from $19

* Nvidia Corp NVDA.O: Rosenblatt Securities adjusts price target to $200 to reflect 10-for-1 stock split

* Nvidia Corp NVDA.O: Wells Fargo raises target price to $155 from $125

* Oge Energy Corp OGE.N: Barclays raises target price to $35 from $34

* Old Dominion Freight Line Inc ODFL.O: Jefferies cuts target price to $185 from $200

* Omega Therapeutics Inc OMGA.O: Raymond James initiates coverage with outperform rating; PT $12

* Oracle Corp ORCL.N: Argus Research raises target price to $159 from $145

* Ovid Therapeutics Inc OVID.O: BTIG cuts target price to $5 from $11

* Ovid Therapeutics Inc OVID.O: Citigroup cuts target price to $1.2 from $3.5

* Ovid Therapeutics Inc OVID.O: H.C. Wainwright cuts target price to $3 from $9

* Ovid Therapeutics Inc OVID.O: Oppenheimer cuts to perform from outperform

* Perspective Therapeutics CATX.A: Oppenheimer raises target price to $19 from $2

* Pilgrims Pride PPC.O: Argus Research initiates coverage with buy rating; PT $41

* Portillos Inc PTLO.O: Guggenheim cuts target price to $18 from $22

* Portillos Inc PTLO.O: Jefferies cuts target price to $18 from $19

* Praxis Precision Medicines Inc PRAX.O: Guggenheim initiates coverage With Buy rating; PT $155

* Primo Water Corp PRMW.N: CIBC raises target price to $26 from $24

* Primo Water Corp PRMW.N: JP Morgan raises target price to $26 from $24

* Primo Water Corp PRMW.N: Raymond James raises target price to $26 from $23

* Primo Water Corp PRMW.N: TD Cowen raises target price to $32 from $30

* Q2 Holdings Inc QTWO.N: Truist Securities raises target price to $68 from $65

* Quinstreet Inc QNST.O: Craig-Hallum raises target price to $22 from $20

* Quinstreet Inc QNST.O: Craig-Hallum raises to buy from hold

* RB Global Inc RBA.N: CIBC initiates coverage with outperformer rating; PT $95

* Reddit RDDT.N: Needham raises target price to $75 from $63

* Repligen Corp RGEN.O: Guggenheim initiates coverage With Neutral rating

* Republic Services Inc RSG.N: Stifel raises target price to $215 from $210

* Silk Road Medical Inc SILK.O: Piper Sandler raises PT to $27.50 from $20

* Steel Dynamics Inc STLD.O: BMO cuts target price to $135 from $140

* Sunoco LP SUN.N: Citigroup raises to buy from neutral

* The Hershey Company HSY.N: Barclays cuts target price to $204 from $210

* Third Harmonic Bio Inc THRD.O: Stifel initiates coverage with buy rating; PT $23

* Transdigm Group Inc TDG.N: RBC raises target price to $1,500 from $1,400

* Triumph Financial Inc TFIN.O: KBW raises target price to $75 from $68

* Urban Outfitters Inc URBN.O: Barclays raises target price to $52 from $50

* Viasat Inc VSAT.O: Morgan Stanley cuts target price to $26 from $28

* Waste Management Inc WM.N: Stifel raises target price to $231 from $227

* Williams Companies Inc WMB.N: Truist Securities raises target price to $42 from $40

* Wingstop Inc WING.O: Stifel raises target price to $460 from $420

* Wolfspeed Inc WOLF.N: Mizuho raises target price to $28 from $27

* Xponential Fitness Inc XPOF.N: Guggenheim raises target price to $20 from $18

* Motorola Solutions Inc MSI.N: Morgan Stanley raises target price to $365 from $335


(Compiled by Bengaluru Newsroom)

</body></html>

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.